Press release

Corporate

Amdocs Announces First Quarter 2026 Investor Conference Schedule


09 Oct 2025

Amdocs Announces First Quarter 2026 Investor Conference Schedule

Layout canvas

JERSEY CITY, NJ – October 9, 2025 – Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced it will attend the following investor conferences during the first quarter of fiscal 2026:

November 18

2025 Wells Fargo 9th Annual TMT Summit Terranea Resort, Rancho Palos Verdes, CA Fireside Chat + Investor meetings Anthony Goonetilleke, Amdocs group president Technology & head of Strategy and Matt Smith, Amdocs head of Investor Relations

November 20-21

6th Annual Needham Tech Week Intercontinental NY Times Square Hotel (Nov 20) and Virtual (Nov 21) Investor meetings Matt Smith, Amdocs head of Investor Relations

December 3

UBS Global Technology & AI Conference The Phoenician Hotel, Scottsdale, AZ Investor meetings Tamar Rapaport-Dagim, Amdocs CFO & COO and Matt Smith, Amdocs head of Investor Relations

December 8

Raymond James TMT & Consumer Conference Lotte New York Palace Hotel, New York, New York Investor meetings Matt Smith, Amdocs head of Investor Relations

December 10

53rd Annual Nasdaq Investor Conference in association with Morgan Stanley The May Fair Hotel, London, England Fireside Chat + Investor meetings Shuky Sheffer, President & CEO and Matt Smith, Amdocs head of Investor Relations

Supporting Resources

About Amdocs

Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers' innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and enterprise customers. Our employees around the globe are here to accelerate service providers' migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $5.00 billion in fiscal 2024. For more information, visit www.amdocs.com

Amdocs' Forward-Looking Statement

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the Company’s customers’ businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company’s customers. Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company’s offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2024, filed on December 17, 2024, and our Form 6-K furnished for the first quarter of fiscal 2025 on February 18, 2025, for the second quarter of fiscal 2025 on May 19, 2025, and for the third quarter of fiscal 2025 on August 18, 2025.

Media Contacts

Matthew Smith
Head of Investor Relations Amdocs
Tel: +1 (314) 212-8328
E-mail: dox_info@amdocs.com